title: Response of immunocompromised children with solid tumors to a conjugate vaccine for Haemophilus influenzae type b.
abstract: Serum antibody response to a conjugated Haemophilus influenzae type b polyribosylribitol phosphate-diphtheria toxoid vaccine was assessed in nonvaccinated children aged 1 1/2 to 5 years receiving chemotherapy for solid tumors. Responses occurred in 21 (42%) of 50 children after first vaccination, and in 10 (45%) of 22 revaccinated children.
authors.affiliation: Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105-2794.
authors.forename: J L
authors.initials: JL
authors.lastname: Shenep
authors.forename: S
authors.initials: S
authors.lastname: Feldman
authors.forename: F
authors.initials: F
authors.lastname: Gigliotti
authors.forename: P K
authors.initials: PK
authors.lastname: Roberson
authors.forename: N
authors.initials: N
authors.lastname: Marina
authors.forename: J E
authors.initials: JE
authors.lastname: Foreschle
authors.forename: G H
authors.initials: GH
authors.lastname: Fullen
authors.forename: L
authors.initials: L
authors.lastname: Lott
authors.forename: T O
authors.initials: TO
authors.lastname: Brodkey
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D002675:Child, Preschool; D004168:Diphtheria Toxoid / Q000276:immunology*; D018073:Haemophilus Vaccines / Q000276:immunology*; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology; D018074:Vaccines, Conjugate / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D018074:Vaccines, Conjugate